Xing H, Tran H C, Knapp T E, Negulescu P A, Pollok B A
Aurora Biosciences Corporation, San Diego, CA 92121, USA.
J Recept Signal Transduct Res. 2000 Nov;20(4):189-210. doi: 10.3109/10799890009150644.
Accompanying the advances in basic biology of G protein-coupled receptors (GPCRs) is the practical need among biopharmaceutical companies for sensitive assays to assess GPCR function, particularly formats that are compatible with high-throughput drug screening. Here we describe a novel cell-based assay format for the high-throughput detection of ligands for Gi protein-coupled receptors. Two Gi-GPCRs, mu-opioid receptor (mu-OPR) and 5-hydroxytryptamine receptor la (5HT1aR) are employed as model receptor targets. The key feature of this assay system is the isolation of stable, clonal Chinese hamster ovary (CHO) cell lines that carry three separate expression plasmids: (1) a chimeric Gq/i5 protein (which re-directs a negative Gi-type signal to a positive Gq-type response), (2) a given Gi-GPCR, and (3) a beta-lactamase (beta1a) reporter gene responsive to Gi-GPCR signaling. Cell-based assays built using this format show appropriate rank order of potency among a reference set of receptor agonist and antagonist compounds. Such assays are also robust, reliable, and can be used for industrial-scale applications such as high-throughput screening for drug leads.
随着G蛋白偶联受体(GPCRs)基础生物学研究的进展,生物制药公司对评估GPCR功能的灵敏检测方法有了实际需求,特别是与高通量药物筛选兼容的检测形式。在此,我们描述了一种基于细胞的新型检测形式,用于高通量检测Gi蛋白偶联受体的配体。两种Gi-GPCR,μ-阿片受体(μ-OPR)和5-羟色胺受体1a(5HT1aR)被用作模型受体靶点。该检测系统的关键特征是分离出携带三种独立表达质粒的稳定克隆中国仓鼠卵巢(CHO)细胞系:(1)一种嵌合Gq/i5蛋白(将负性Gi型信号重定向为正性Gq型反应),(2)一种特定的Gi-GPCR,以及(3)一个对Gi-GPCR信号传导有反应的β-内酰胺酶(β1a)报告基因。使用这种形式构建的基于细胞的检测在一组参考受体激动剂和拮抗剂化合物中显示出适当的效价顺序。此类检测也具有稳健性、可靠性,可用于工业规模应用,如药物先导物的高通量筛选。